|Articles|November 15, 2002

BioPharm International

  • BioPharm International-11-01-2002
  • Volume 15
  • Issue 11

Survival Guide to FDA Inspections: Part 3, Responding to Observations

by Massoud Lavian and Paul W. Allen, Clarkston Consulting
To view a PDF of this article from the BioPharm International archives, click this link

Articles in this issue

almost 23 years ago

Outsourcing Outlook: Will CROs find opportunity in a Reinvigorated European R&D Sector?

almost 23 years ago

Inside Washington: Major Changes Ahead for FDA

almost 23 years ago

Bioinformatics Databases ? Questions of Copyright

almost 23 years ago

European Editor's Report ? An Industry Comes of Age

almost 23 years ago

Guest Editorial: Back to the Beginning

almost 23 years ago

Employing Near-Infrared Spectroscopic Methods of Analysis for Fermentation Monitoring and Control: Part 1, Method Development

almost 23 years ago

You Have Failed . . . A Case Study in Warning Letter Remediation

almost 23 years ago

Analytical Advances: The Protein ID Autobahn ? Automated Nanoelectrospray Mass Spectrometry

Newsletter

Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.

Subscribe Now!
Contact Info

259 Prospect Plains Rd, Bldg H
Cranbury, NJ 08512

609-716-7777

Brand Logo

© 2025 MJH Life Sciences®

All rights reserved.

Home
About Us
News
Contact Us